Relay Therapeutics is trading at $17.06, up 4.79%, with no clear catalyst identified.
- No fresh company-specific news was identified for October 19; the Phase 3 milestone story was announced September 22, not overnight.
- Biotech was down in the premarket sector context, opposite Relay Therapeutics’ move.
- No volume data was provided.